the court addressed the issue of whether the pharmacist’s failure to dispense the FDA mandated PPI for progesterone was the proximate cause of a congenital eye defect that occurred. Because congenital defects, but not eye deformities, were specified in the PPI, failure to provide the PPI could not be proven to be the proximate cause. Therefore, judgment was in favor of the pharmacy.